Welcome to our Infectious Diseases Fellowship Website

Apply Now

The combined Rush University Medical Center (RUMC) and Cook County Health (CCH) Infectious Diseases Fellowship Program provides a two-year curriculum with an optional third year of training that is dedicated to training successful Infectious Diseases physicians with the essential building blocks for any desired career path in the field. We have more than 40 faculty who specialize in 12 areas of divisional expertise and are world leaders in HIV and healthcare epidemiology research. Situated in the amazing city of Chicago, fellows can enjoy all of our program advantages and explore all that the city has to offer.

Thank you for your interest in our program!

 

 

Rush
RUSH Goes Social!
We are excited to announce the expansion of our social media presence with the launch of our official Twitter (@RushCCH_ID) and Instagram (@rushcchid) accounts! Be sure to follow us to stay up-to-date on our fellowship program.
Rush University Medical Center Ranked Among Top 20 U.S Hospitals
Rush has earned a top spot on U.S. News & World Report’s annual Best Hospitals Roll. Read more…
Mary HaydenFaculty Accomplishments
Congratulations to Dr. Mary Hayden for her appointment as the 2020 President-Elect for The Society of Healthcare Epidemiology of America (SHEA) Board of Trustees, where she will continue to serve as a national leader in healthcare epidemiology and antibiotic stewardship.
Beverly ShaFaculty Accomplishments
Dr. Beverly Sha recently received the 2019-2020 Rush Faculty Excellence Award in Clinical Service, which recognizes her work and dedication in education, research, mentoring, and clinical and community service. Read more…

 
ID Fellows 2020
 
We welcome our new Infectious Disease Fellows!

On July 1st, amid the COVID-19 pandemic, we officially welcomed our new Infectious Disease Fellows with a fun-filled scavenger hunt, giving them the opportunity to meet their new colleagues while getting to know the Rush Campus firsthand. In turn, we sadly bade farewell to our graduating fellows. In celebration of their achievement, they enjoyed an authentic meal from Osterio via Stato and received framed artwork from Snow City Arts Foundation.

Dr. Do Young Kim LEAP FellowshipFellows Accomplishments
Dr. Do Young Kim, our third-year research fellow, was one of four national awardees to receive the 2020-2021 Leadership in Epidemiology, Antibiotic Stewardship, and Public Health (LEAP) fellowship sponsored by the Centers for Disease Control and Prevention (CDC). His project is titled “Checking Live Virus to Ascertain Time to Clearance of Viable Virus in severe COVID-19 Pneumonia”. Read more…
 
Sarah WonFaculty Accomplishments
Congratulations to Dr. Sarah Won for receiving the Rush Department of Internal Medicine 2019-2020 Attending Teaching Award!
Fellows News
Fellows Outing - November 2019
Our ID Fellows spent a fun-filled Saturday bouldering at a local climbing studio followed by dinner at one of Chicago’s barbeque hot spots, Green Street Smoked Meats. The event provided an opportunity for the fellows to foster relationships outside of work while enjoying some the exciting activites Chicago has to offer.
ID Fellow Outing, Green Street Smoked Meats
ID Fellow Outing, BoulderingID Fellow Outing, Bouldering
IDWeek 2019 - Washington, DC
Rush University Medical Center had an active participation at the IDWeek, held in Washington, DC from October 2nd to October 6th, 2019. RUMC/CCH faculty and fellows contributed to 7 oral abstracts and 6 poster presentations. We had a fantastic time at our annual IDWeek RUMC/CCH gathering at City Tap House in Penn Quarter where we had a chance to hangout with our previous fellows and catch up with their wonderful experiences!
Weinstein IDWeek 2019CONGRATULATIONS TO…
Dr. Robert A. Weinstein, Professor of Internal Medicine, Division of Infectious Diseases at RUMC and Chairman Emiratus at CCH, on receiving the prestigious SHEA Senior Scholarship Award at the IDWeek 2019.

Oral Presentations:

  • Lin MY, Tang A, Fealy AE, Gao W, Markovski G, Xiang Y, Trick W. First five years of experience with the illinois extensively Drug resistant organism (XDRO) registry and implementation of automated alerting. Abstract no. 82, IDWeek 2019, Washington DC, October 2-6, 2019
  • McKinnell JA, Singh R, Miller LG, Saavedra R, Heim L, Gussin G, Lewis B, Estevez M, Catuna TD, Lee E, He J, Kleinman K, Shimabuduo J, Evans K, Bittencourt C, Baesu C, Gohil SK, Park S, Tam S, Robinson PA, Slayton R, Stone ND, Jernigan JA, Zahn M, Janssen L, O’Donnell K, Weinstein RA, Hayden MK, lee BY, Mueller LE, Bartsch SM, Peterson EM, Huang SS. The SHIELD Orange County Project: A decolonization strategy in 35 hospitals and nursing homes reduces multi-drug resistant organisms (MDRO) prevalence in Southern California region. Abstract no. 893, IDWeek 2019, Washington DC, October 2-6, 2019
  • Rhee Y, Hayden MK, Simms AT, Yelin RD, Lolans K, Bell PB, Schoeny M, Baker AW, Gohil SK, Rhee C, Talati N, Warren DK, Welbel SF, Dangana TE, Bravo H, Cass C, Nelson A, Tolomeo PC, Wolf R, Lin MY. Impact of measurement and results feedback of chlorhexidine gluconate (CHG) skin concentrations in medical intensive care unit (MICU) patients receiving CHG bathing. Abstract no. 895, IDWeek 2019, Washington DC, October 2-6, 2019
  • Hayden MK, Dangana TE, Yelin RD, Schoeny M, Stanley M, Preite N, Kahn N, Edomwande O, Black SR, Pacilli M, Xin H, Deming C, Lin MY, Segre JA. Prevalence of Candida auris at body Sites, characterization of skin microbiota, and relation of chlorhexidine gluconate (CHG) skin concentration to C. auris detection among patients at a high-prevalence ventilator-capable skilled nursing facility (vSNF) with established CHG bathing. Abstract no. 87, IDWeek 2019, Washington DC, October 2-6, 2019
  • Huhn GD, Ramgopal M, Crofoot G, Gatje J, Seyedkazemi S, Cosler P, Simonson RB, Luo D, Dunn K. High rates of virological suppression achieved in HIV-1-infected adults rapidly starting antiretroviral therapy (ART) with the single-tablet regimen (STR) of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) 800/150/200/10 mg regardless of baseline disease characteristics: Week 48 subgroup analysis from the phase 3 DIAMOND Trial. Abstract no. 887, IDWeek 2019, Washington DC, October 2-6, 2019
  • Bassis C, Seekatz A, Dangana TE, Shimasaki T, Yelin RD, Schoeny M, Rhee Y, Ariston M, Lolans K, Cornejo-Cisneros E, Aboushaala K, Thabit L, Murray J, Ollison S, Bell PB, Fogg L, Weinstein RA, Lin MY, Young VB, Hayden MK. Gut microbiota differenes at the time of medical intensive care unit (MICU) admission are associated with acquisition of multidrug-resistant organisms (MDRO) among patients not already colonized with a MDRO. Abstract no. 2849, IDWeek 2019, Washington DC, October 2-6, 2019

Poster Presentations:

  • Rhee Y, Hayden MK, Simms AT, Yelin RD, Lolans K, Bell PB, Schoeny M, Baker AWm Gohil SK, Rhee C, Talati NJ, Warren DK, Welbel SF, Dangana TE, Majalca T, Bravo H, Css C, Nelson A, Tolomeo PC, Wolf R, Lin MY. Relationship between chlorohexidine gluconate (CHG) skin concentrations and microbial skin colonization among medical intensive care units (MICU) patients. Abstract no. 572, IDWeek 2019, Washington DC, October 2-6, 2019
  • Young VB, Keidan M, Yelin RD,  Dangana TE, Bell PB, Rao K, Hayden MK. Shedding of viable Clostridioldes difficile in patients admitted to a medical intensive care unit. Abstract no. 2424, IDWeek 2019, Washington DC, October 2-6, 2019
  • Sansom S, Moore NMKazi AS, Won SY. Effect of adjusted CLSI breakpoints on center-wide fluoroquinolone susceptibilities for Enterobacteriaceae and Pseudomonas aeruginosa: Is it time to restrict empiric fluoroquinolone use? Abstract no. 2184, IDWeek 2019, Washington DC, October 2-6, 2019
  • Kazi AS, Sansom S, Varughese C, Hodgson  HA, Won SY. Love thy steward - who does not love antimicrobial stewardship. Abstract no. 1043, IDWeek 2019, Washington DC, October 2-6, 2019
  • Patel PV, Nash CB, Vu BN. Evaluation of neonatal sepsis guidelines in a neonatal intensive care unit. Abstract no. 1040, IDWeek 2019, Washington DC, October 2-6, 2019
  • Rynkiewich K, Schwartz D, Won SY, Heber M, Timmereddy K, Stoner B. An ethnographic approach to interrogating animicrobial stewardship at US teaching hospitals. Abstract no. 1091, IDWeek 2019, Washington DC, October 2-6, 2019
  • Rhee Y, Hayden MK, Simms AT, Yelin RD, Lolans K, Bell PB, Schoeny M, Baker AW, Baker MA, Hohil SK, Rhee C, Talati NJ, Warren DK, Welbel SF, Dangana TE, Majalca T, Bravo H, Cass C, Nelson A, Tolomeo PC, Wolf R, Lin MY. Relationship between chlorhexidine gluconate (CHG) skin concentration and microbial skin oolonization among medical intensive care unit. Abstract no. 572, IDWeek 2019, Washington DC, October 2-6, 2019
  • Medernach RL, Domitrovic TN, Hayani KC, Hujer AM, Qureshi NK, Marshall SH, Nguyen DC, Rudin SD, Rispens JR, Zheng X, Weinstein RA, Bonomo RA, Logan LK. Multi-centered study of the clinical and molecular epidemiology of AmpC cephalosporinase-producing Enterobacteriaceae infections in children. Abstract no. 594, IDWeek 2019, Washington DC, October 2-6, 2019

 

Faculty Accomplishments
Our RUMC/CCH faculty has successfully put together The Chicago Infectious Disease Board Review. Check out the link below for more information:
  ID Board Review Course

  Archived Announcements

 How to apply

Positions are currently available for five first-year fellows. Find full details and begin your application